• BIVDA members area

Members' Press Releases

From the monthly archives: June, 2016

We are pleased to present below all posts archived in 'June, 2016'. If you still can't find what you are looking for, try using the search box.

Sebia, specialist in electrophoresis will distribute worldwide Seralite®– FLC serum lateral flow immunoassays for the diagnosis and monitoring of multiple Myeloma

Abingdon Health

Paris, France, and York, UK, June 27, 2016 – Sebia, the world leader in medical diagnostics by electrophoresis, and Abingdon Health, an in-vitro diagnostic group, today announce that they have entered into a multi-year, exclusive, global distribution agreement. The deal allows Sebia to add Abingdon Health’s Seralite®– FLC Dual Kappa and Lambda serum lateral flow immunoassay to its worldwide offering. The financial terms of the agreement have not been disclosed.

Read the rest of entry »

AGM Statement and Result of AGM

Proteome Sciences

24 June 2016

At the AGM held earlier today it was announced that revenues from the core biomarker services activities remained buoyant in the first half with a strong order book, including repeat business, and a developing pipeline. TMT revenue growth has continued into 2016 and TMT was highly visible at the recent meeting of the American Society for Mass Spectrometry.

Read the rest of entry »

Increased efficiency and faster viral load results with DxN VERIS Molecular Diagnostics System

Beckman Coulter

Niguarda Hospital, Milan, shares experiences in newly available case study

Nyon, Switzerland — (21 June 2016) — A newly released case study, available from Beckman Coulter, describes the experiences of Niguarda Hospital’s Molecular Biology Laboratory in the assessment of the DxN VERIS Molecular Diagnostics System.  Involving fewer steps and reagents, and with true, single sample random access, DxN VERIS incr

Read the rest of entry »

Study shows efficacy of Beckman Coulter DxN VERIS Molecular Diagnostics System for monitoring CMV-DNA in plasma samples

Beckman Coulter

Nyon, Switzerland — (14 June 2016) — Beckman Coulter is pleased to highlight results published in the Journal of Clinical Virology1 that show the company’s DxN VERIS VERIS CMV Assay is more sensitive, and the DxN VERIS Molecular Diagnostics System has greater ease-of-use benefits , than another commercially available testing system.

Read the rest of entry »

Excellent results reported for DxN VERIS Molecular Diagnostic System HIV-1 Assay at multiple centres across Europe

Beckman Coulter

Nyon, Switzerland — (07 June 2016) —Beckman Coulter is pleased to highlight the findings of a poster, presented at ECCMID, Amsterdam, 2016, regarding the analytical performance of the company’s fully automated DxN VERIS Molecular Diagnostics System and VERIS HIV-1 Assay

Read the rest of entry »

Archive